title: Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708.
authors.affiliation: MRC Clinical Trials Unit at University College London, London, UK. Electronic address: m.sydes@ucl.ac.uk.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Sydes
authors.affiliation: MRC Clinical Trials Unit at University College London, London, UK.
authors.forename: Alastair W S
authors.initials: AWS
authors.lastname: Ritchie
authors.affiliation: University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK.
authors.forename: Nicholas D
authors.initials: ND
authors.lastname: James
mesh_terms: D001290:Attitude; D000077143:Docetaxel; D006801:Humans; D008297:Male; D010984:Platinum; D011471:Prostatic Neoplasms; D043823:Taxoids
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D010984:Platinum